German drugmaker Bayer AG (BAYN.ETR) agreed to buy Kunming-based Dihon Pharmaceutical Group to gain Chinese over-the-counter products and traditional herbal treatments, Bloomberg reported, citing a statement by CEO Marijn Dekkers. Bayer said it expects the deal to close in the second half of the year, pending regulatory approval. “This acquisition moves us into a leading […]
Category: Health Care
UK drugmaker GlaxoSmithKline (GSK; GSK.NYSE, GSK.LON) CEO Andrew Witty was paid a reduced bonus for 2013 because of a Chinese anti-corruption probe focused on the UK drugmaker, Bloomberg reported, citing Glaxo’s annual report released on Thursday. Witty’s bonus of US$3.13 million was lower than the maximum US$3.66 million he might have received. China began investigating […]
US-based Brigham and Women’s Hospital is weighing a proposal from real estate tycoon Hui Ka Yan to be the first Harvard University-affiliated hospital to expand to China, Bloomberg reported, citing hospital spokeswoman Erin McDonough. In a statement, McDonough said that Brigham and Women’s Hospital is exploring “the possibility of collaborating” with Hui’s Evergrande Real Estate […]
Chinese drug producer Luye Pharma Group is poised to raise around US$750 million through an IPO in Hong Kong, The Wall Street Journal reported, citing people familiar with the matter. After delisting from the Singapore stock exchange in 2012, the pharmaceutical company won’t go public again until the second quarter at the earliest. The IPO, […]
China saw an alarming rise of new cancer cases and deaths in 2012 amid a global rise of the disease, with the country registering the most new cancer cases and deaths from four types of malignant tumors, South China Morning Post reported. In the latest edition of the World Cancer Report, China accounted for 3.07 […]